Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories - Wikidata - awgldk - TriplyDB

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

http://www.wikidata.org/entity/Q27028051

about

Rapid characterization of microorganisms by mass spectrometry--what can be learned and how?Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)Detection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry Rapid clinical bacteriology and its future impact Bioinformatics Education in Pathology Training: Current Scope and Future Direction.Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment Emerging mass spectrometry techniques for the direct analysis of microbial colonies.Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization-time of flight mass spectrometry.Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance Identification of Tsetse (Glossina spp.) using matrix-assisted laser desorption/ionisation time of flight mass spectrometry.Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.Rapid intrinsic fluorescence method for direct identification of pathogens in blood cultures.An initial assessment of correlations between host- and virus-related factors affecting analogues antiviral therapy in HBV chronically infected patients Identification of clinical yeasts by Vitek MS system compared with API ID 32 C.Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS.Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia Comparison of MALDI-TOF MS and AFLP for strain typing of ESBL-producing Escherichia coli.Applications of MALDI-TOF MS in environmental microbiology.Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts.Advances in medical diagnosis of intra-amniotic infection.Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus.Application of maldi-tof mass spectrometry in clinical virology: a review.Timely approaches to identify probiotic species of the genus Lactobacillus.Next-generation antimicrobial susceptibility testing.Genotyping Streptococcus pneumoniae.Mycobacterium diagnostics: from the primitive to the promising.Mass spectrometry methods for predicting antibiotic resistance.How many human proteoforms are there?An Automated Sample Preparation Instrument to Accelerate Positive Blood Cultures Microbial Identification by MALDI-TOF Mass Spectrometry (Vitek®MS).

P2860

Q26822246-27D2D30B-CF34-4BBA-A5F3-F398F8CA26B1 Q28384972-ED2E36B2-5860-4418-BF78-5A8C027047D3 Q28727420-CBA6FA06-68B1-4420-BC13-46DC904D7BDD Q30459288-71FBA16D-7B77-43BF-8CC4-45D8914E5667 Q33565853-56D29583-D367-4E12-8CF3-5881B3E7707A Q33762602-5C78C048-8D94-49B9-A5B8-68E58F4A05D7 Q34165254-EC4AEF1E-CEF9-4741-8AFA-2EEF12ECB241 Q34311423-80F30BD6-D616-490D-9D0A-172ABC7A3EBD Q34725107-99C209A8-C347-4C4A-8A57-218E965C228D Q34855259-EC411C8D-190A-4764-96AD-D68E04DC2031 Q34982516-3BFAA280-FD0D-4F08-BB28-5B5A865DC39A Q35047371-0B11B987-1E42-4462-BC03-EDE78F990220 Q35102963-71DEE2C4-B67D-4555-8749-49ADA6A00983 Q35159886-BCDD8BE1-8BF2-4A0E-8B4E-BE2E53F946E7 Q35763995-66D1E121-3205-4482-A06B-60F3890D3BCC Q35799878-6A0FE2E7-2FC2-4939-8663-402DAC843E1E Q35938295-22D3DA28-0545-4794-9637-0A20F5C05C15 Q35987840-34C7F64E-BE37-4EF0-9957-77B4ACF48927 Q36225962-2EB316D3-C3DF-4D12-90DF-A756EA0659D2 Q37214603-A6BA6A44-5601-4A0D-84CD-28602576FF11 Q37264361-94C9B2C9-9CD2-4861-BE60-303AB480E67E Q37289797-1124DFF2-6F51-48CB-8192-78F736F249A7 Q37360378-5ABB0C7C-9B17-479E-94AD-02B79E5206DB Q38088958-402597F8-68AB-4592-A12B-17282FF1DDBB Q38417048-9B111310-7900-4D14-B297-85118C4BDBB2 Q38438695-DD5C7A48-F710-493F-B050-32299A9EBC76 Q38867552-49DC08C6-39A4-493B-8264-4B769989488E Q50001631-7E79DBFF-8D3C-4A5B-AF09-252CE32BB550 Q55262380-F4D99763-4FFA-4EC3-93A8-D75E87168AFD

P2860

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

http://www.wikidata.org/entity/Q27028051

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@ast

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@en

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@nl

type

label

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@ast

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@en

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@nl

prefLabel

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@ast

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@en

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@nl

P1433

Q27028051-81B4AAC2-9CFE-4543-8BB5-74C52386EE26

P1476

Q27028051-9B676A29-A462-4D40-BCCB-827C862E2A08

P2093

Q27028051-55B15710-CA80-4642-B703-5238371BA75E

Q27028051-9ACA7388-17AE-498E-811C-9CCE74CE35AF

Q27028051-9F0251A3-C77A-44FE-81EE-028D3446935F

Q27028051-B7A9A736-08CC-42AA-A2ED-25CF91282889

P2860

Q27028051-0DBF93C4-23F6-43A9-9F9D-9508968A2D25

Q27028051-18DCD91E-0310-47B0-950E-3D16787A2245

Q27028051-1F7E9FAB-5233-4860-9132-76F780353953

Q27028051-2182785F-553F-4B40-8819-DB80774A9B4E

Q27028051-2481CD39-325E-44EB-AA2F-C67C86382972

Q27028051-3E37DA05-9DE8-4F35-95CF-BCE61F9ED8A2

Q27028051-3F843B0D-9CF5-4D50-AF9A-1A16ADE16CC9

Q27028051-42855C22-D530-4FF6-8387-0595DDCEABC5

Q27028051-4EBC56DD-FE5A-4E7A-A559-2E772AE6CDFD

Q27028051-672917F8-92A9-4AD0-B2D5-4FDEB23F448E

P304

Q27028051-D573CE2F-5663-48C1-9C2E-99C0167ECFF1

P31

Q27028051-B365F9DF-C805-4BCD-BB3C-0C0FFB0994EB

P356

Q27028051-0B1AA6AF-71DF-49E3-9BB5-392FCE459728

P407

Q27028051-FC8D15A0-4DA0-4BB9-B3F8-FCB6DA61BDE3

P433

Q27028051-3939606F-88D0-4DAA-8E07-492D4D37678C

P478

Q27028051-4938139D-12B3-43AE-9889-CDB7348460E5

P577

Q27028051-80DA2722-36FA-4D1F-8D8D-7DF05484AD01

P5875

Q27028051-344115FF-7781-4E27-8E43-A6BDA7418C10

P698

Q27028051-870ECCF6-14AB-43D1-B4C1-86722CC232EB

P932

Q27028051-04E0BC0A-2D89-4BEE-B2B6-4236A7DF7B8F

P356

P1433

Journal of Clinical Microbiology

P1476

Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories

@en

P2093

A. van Belkum

http://www.w3.org/2001/XMLSchema#string

M. Erhard

http://www.w3.org/2001/XMLSchema#string

M. Welker

http://www.w3.org/2001/XMLSchema#string

S. Chatellier

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice

Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry.

Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus

Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level

Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages.

Differential proteome analysis of Mycobacterium avium subsp. paratuberculosis grown in vitro and isolated from cases of clinical Johne's disease.

Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria.

P304

1513-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00420-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221854148

http://www.w3.org/2001/XMLSchema#string

P698

22357505

http://www.w3.org/2001/XMLSchema#string

P932

3347093

http://www.w3.org/2001/XMLSchema#string